Related Experiment Video
Updated: Jun 17, 2026
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
[Hypofractionated stereotactic radiotherapy for brain metastases]
M Schlienger1, F Nataf, F Huguet
1Service d'oncologie-radiothérapie, hôpital Tenon, 4 rue de la Chine, Paris, France. michel.schlienger@tnn.aphp.fr
Summary
Both radiosurgery and hypofractionated stereotactic radiotherapy are effective for treating brain metastases larger than 500 mm³. For smaller lesions, radiosurgery with invasive immobilization is preferred, while larger tumors may benefit from hypofractionated radiotherapy.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Oncology
Context:
- Brain metastases pose a significant challenge in cancer treatment.
- Choosing between radiosurgery and hypofractionated stereotactic radiotherapy is crucial for optimal patient outcomes.
- Literature review identifies key parameters for treatment selection.
Purpose:
- To compare radiosurgery and hypofractionated stereotactic radiotherapy for brain metastases.
- To provide evidence-based guidance for treatment modality selection.
- To analyze efficacy and toxicity based on tumor volume and treatment parameters.
Summary:
- Hypofractionated stereotactic radiotherapy and radiosurgery demonstrated similar efficacy for brain metastases between 500-4200 mm³ GTV.
- Radiosurgery with invasive immobilization is recommended for smaller lesions (<500 mm³).
- Hypofractionated stereotactic radiotherapy may be suitable for larger lesions (>4200 mm³) with further study.
Impact:
- Informs clinical decision-making for brain metastases treatment.
- Highlights the importance of tumor size and immobilization technique in treatment planning.
- Suggests future research directions for optimizing hypofractionated stereotactic radiotherapy parameters.
